Cargando…

Botulinum toxin in high-risk BPH patients in retention

Detalles Bibliográficos
Autores principales:	Reddy, Sreedhar, Chawla, Arun, Thomas, Joseph
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684261/ https://www.ncbi.nlm.nih.gov/pubmed/19468419

Ejemplares similares

Risk factors for persistent stress urinary incontinence after mid-urethral procedures
por: Chawla, Arun, et al.
Publicado: (2008)

Combined dorsal plus ventral double buccal mucosa graft in bulbar urethral reconstruction
por: Chawla, Arun, et al.
Publicado: (2008)

Can micturating cystourethrograms be avoided in follow-up of antenatally diagnosed hydronephrosis?
por: Chawla, Arun, et al.
Publicado: (2008)

Can suppressive antibiotics be avoided in the postnatal management of antenatally detected obstructive hydronephrosis?
por: Reddy, Sreedhar V., et al.
Publicado: (2007)

Relevance of inflammatory pseudotumor associated with bladder tumor
por: Kurien, Annamma, et al.
Publicado: (2007)

Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009)

L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH
por: Gupta, Saurabh
Publicado: (2014)

Can early salvage radiotherapy replace adjuvant radiotherapy as the new standard of care for high-risk postradical prostatectomy patients?
por: Pandey, Abhishek
Publicado: (2021)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Checkmate 274 trial: Is Nivolumab the new standard in adjuvant setting for high-risk muscle invasive urothelial carcinoma?
por: Kumar, Naveen
Publicado: (2021)

LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
por: Kumar, Gautam
Publicado: (2020)

Comparing outcomes between neoadjuvant hormonal therapy followed by prostatectomy versus upfront prostatectomy in high-risk prostate cancer: The road ahead
por: Bhargava, Priyank
Publicado: (2023)

Neoadjuvant androgen suppression in patients treated with high-intensity focused ultrasound therapy
por: Khochikar, Makarand V.
Publicado: (2007)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

Does early orchidopexy reduce risk of testicular cancer?
por: Banerji, John S., et al.
Publicado: (2008)

Prostate cancer treatment does not increase the risk of cardiovascular events
por: Khochikar, Makarand V.
Publicado: (2007)

Safety and efficacy of active surveillance in patients with localized prostate cancer
por: Mavuduru, Ravimohan, et al.
Publicado: (2008)

Renal and testicular involvement in COVID-19 patients – implication for the urologist
por: Pandey, Abhisek
Publicado: (2020)

A novel approach to management of nocturia in patients with benign prostatic hyperplasia
por: Sengottayan, Vengetesh K., et al.
Publicado: (2009)

Is incidence of prostate cancer higher in patients with end stage renal disease?
por: Khochikar, Makarand V.
Publicado: (2007)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

Malignant ureteral obstruction: Whether decompression really improves patient outcomes and quality of life?
por: Muruganandham, K., et al.
Publicado: (2008)

What happens to the patients with muscle-invasive bladder cancer who refuse cystectomy after neoadjuvant chemotherapy?
por: Maheshwari, Ruchir, et al.
Publicado: (2009)

The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
por: Agrawal, Sumit
Publicado: (2020)

ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?
por: Kumar, Naveen
Publicado: (2022)

Intravesical real-time imaging and staging of bladder cancer: Use of optical coherence tomography
por: Sengottayan, Vengatesh K., et al.
Publicado: (2008)

Survival following primary androgen deprivation therapy among men with localized prostate cancer
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Is lap nephrectomy superior to open? A randomized trial
por: Kumar, Anup, et al.
Publicado: (2008)

Does tamsulosin facilitate expulsion of distal ureteric calculus following lithotripsy?
por: Gupta, Gaurav, et al.
Publicado: (2008)

Partial nephrectomy for small renal tumors may prevent chronic kidney disease
por: Kumar, Rajeev
Publicado: (2008)

Urethral reconstructive surgery: Which catheters are better?
por: Suryavanshi, Manav, et al.
Publicado: (2008)

Ureteroilleal anastomosis in orthotopic ileal neobladders: Does technique matter?
por: Gupta, Parag, et al.
Publicado: (2008)

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
por: Vasudeva, Pawan, et al.
Publicado: (2008)

What is the treatment of choice for bulbar urethral strictures which are not an indication for visual internal urethrotomy?
por: Dubey, Deepak, et al.
Publicado: (2008)

Follow-up after pyeloplasty: How long?
por: Nirmal, T. J., et al.
Publicado: (2008)

Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial
por: Dubey, Deepak, et al.
Publicado: (2008)

Optimizing bowel recovery after laparoscopic donor nephrectomy
por: Prakash, Gagan, et al.
Publicado: (2008)

Nitrous oxide during anesthesia for laparoscopic donor nephrectomy: Does it matter?
por: Singh, Pratipal, et al.
Publicado: (2008)

Can tomato juice be used for prophylaxis in recurrent stone formers?
por: Agrawal, Madhu S., et al.
Publicado: (2009)

Antibiotic prophylaxis in vesicoureteral reflux: A paradigm shift
por: Banerji, J. S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pbljuoupqco8bdbddvfot4140t